Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tricuspid Valve-in-Valve Procedure with An Edwards S3 Valve in a 15-kg Child in Latin America

Autor: Becerra, Albert Franz Guerrero, Arevalo, Jaime Ramon Cabrales, Senosiain, Julian, Torres, Alberto Enrique Garcia, Camacho, Jaime, Reyes, Nestor Fernando Sandoval

Publikováno v: Brazilian Journal of Cardiovascular Surgery, Issue: ahead, Published: 24 OCT 2022
Brazilian Journal of Cardiovascular Surgery n.ahead 2022
Brazilian Journal of Cardiovascular Surgery
Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
Brazilian Journal of Cardiovascular Surgery, Volume: 38, Issue: 1, Pages: 201-203, Published: 24 OCT 2022

A 5-year-old child, weighing 15 kg, with three previous sternotomies, presented with right heart failure due to severe stenosis and regurgitation of the bioprosthetic tricuspid valve. A percutaneous tricuspid valve-in-valve procedure with an Edwards

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::27651c9eb438ee7d933ce0a9cd9fe04a
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382022005008203&lng=en&tlng=en

Isquemia crónica amenazante de miembros inferiores: intervenciones y desenlaces

Autor: Barrera Carvajal, Juan Guillermo, Camacho Mackenzie, Jaime, Cabrales Arevalo, Jaime Ramon, Molano-González, Nicolas

Publikováno v: Sharma SK, Kohli A, Chopra E. Peripheral arterial disease (PAD) assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherosclerosis. Indian J Thorac Cardiovasc Surg. 2016;32(2):120–5.
Zeymer U, Parhofer KG, Pittrow D, Binz C, Schwertfeger M, Limbourg T, et al. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: Results of the prospective German REACH registry cohort. Clin Res Cardiol. 2009;98(4):249–56.
Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg [Internet]. 2016 [cited 2018 Nov 28];64(1):e1–21. Available from: http://dx.doi.org/10.1016/j.jvs.2016.03.420
Conte MS, Bradbury AW, Kolh P, White J V, Dick F, Fitridge R, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg [Internet]. 2019;58(1):S1-S1-S109.e33.
Darling JD, Mccallum JC, Soden PA, Korepta L, Guzman RJ, Wyers MC, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg [Internet]. 2017 Aug [cited 2019 Feb 8];66(2):466–75.
Darling JD, Bodewes TCF, Deery SE, Guzman RJ, Wyers MC, Hamdan AD, et al. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes. J Vasc Surg [Internet]. 2018;67(4):1159–69.
Kok HK, Asadi H, Sheehan M, McGrath FP, Given MF, Lee MJ. Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification. Diagnostic Interv Radiol. 2017;23(5):360–4.
Sr MJL, MS C, DG A, FB P, Schanzer A, AN S, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). Journal of Vascular Surgery. Jan 01, 2014 59(1):220-234e2
Kinlay S. Management of Critical Limb Ischemia. Circ Cardiovasc Interv. 2016 February ; 9(2): e001946
Xiao Y, Chen Z, Yang Y, Kou L. Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease. Diagnostic Interv Radiol 2016 Feb 8;22(5):436–43.
Pisarchik A V., Yarmolinskii DG, Demidchik YE, Ermak GZ, Kartei NA, Figge J. The ref/PTCl and ref/PTC3rl rearrangements in thyroid carcinoma cells from the inhabitants of belarus after the chernobyl accident. Genetika 2000;36(7):959–64.
Lo RC, Darling J, Bensley RP, Giles KA, Dahlberg SE, Hamdan AD, et al. Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg 2013 Feb 10;57(6):1455–63.
Aburahma AF. When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease? Ann Vasc Dis 2018 Feb 10;11(1):25–40.
Ko SH, Bandyk DF. Therapeutic angiogenesis for critical limb ischemia Vol. 27, Seminars in Vascular Surgery. 2014 p. 23–31.
Gerald F, Fowkes R, Rudan D, Rudan I, Aboyans V, Denenberg JO, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. www.thelancet.com 2019 Mar 22;1329. doi.org/10.1016/
Veith FJ, Gupta SK, Wengerter KR, et al. Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia. Ann Surg. 1990;212(4):402-414. doi:10.1097/00000658-199010000-00003
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-S67. doi:10.1016/j.jvs.2006.12.037
Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2):384-392. doi:10.1093/ije/20.2.384
Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381-386. doi:10.1056/NEJM199202063260605
Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31(1):42-48. doi:10.1136/jech.31.1.42
AM AD, MW S, Undavalli C, Asi N, Wang Z, MB E, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 2015 Dec;62(6):1642-51.e3. doi: 10.1016/j.jvs.2015.07.065.
Bradbury AW, Adam DJ, Beard JD, Cleveland T, Forbes JF, Fowkes FGR, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.
AW B, DJ A, Bell J, JF F, FG F, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg. 2010 May;51(5 Suppl):52S-68S.
JJ S, ZS H, HL G, Parrack I, DB S, PH C, et al. Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia. Vasc Health Risk Manag 2014 Jun 23;10:367-74. doi: 10.2147/VHRM.S54350.
JP S, PP G, Flahive J, AW H, JW H, LW K, et al. A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass. J Vasc Surg 2016 Apr;63(4):990-7. doi: 10.1016/j.jvs.2015.09.051.
Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D, et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv 2014 Dec;7(12):1444-9.
SM T, CA K, DW B, AL C, EA T, 3rd LEM, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 2006 Oct;44(4):747-55; discussion 755-6.
Biancari F, Ylönen K, Salenius J-P, Heikkinen M, Luther M, Lepäntalo M. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: A finnvasc registry study. World J Surg 2007 Jan;31(1):217-25; discussion 226-7 doi:10.1007/s00268-006-0242-y.
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States-Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004 Aug 10;110(6):738-43. doi: 10.1161/01.CIR.0000137913.26087.F0. Epub 2004 Jul 19.
Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease. Vasa 2004 Nov;33(4):183-9. doi: 10.1024/0301-1526.33.4.183.
Corrections: Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic-specific Prevalence of Peripheral Arterial Disease in the United States. Am J Prev Med 2007;32(4):328–33.
Lu L, DF M, JP P. Secondhand smoke exposure and intermittent claudication: a Scotland-wide study of 4231 non-smokers. Heart 2013 Sep;99(18):1342-5. doi: 10.1136/heartjnl-2013-304226. Epub 2013 Jul 19.
EB J, SO O, Chalmers N, AJ B. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001 Aug;24(8):1433-7. doi: 10.2337/diacare.24.8.1433.
Criqui MH, Vargas V, Denenberg JO. Abstract: Ethnicity and peripheral arterial disease: The San Diego Population Study. Circulation 2005 Oct 25;112(17):2703-7. doi: 10.1161/CIRCULATIONAHA.105.546507.
Ridker PM, Stampfer MJ, Rifai N. Preventive Cardiology Abstracts: Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001 May 16;285(19):2481-5. doi:10.1001/jama.285.19.2481.
Conen D, KM R, MA C, PM R, AD P. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation 2009 Sep 22;120(12):1041-7. doi: 10.1161/CIRCULATIONAHA.109.863092. Epub 2009 Sep 8.
Vidula H, Liu K, MH C, Szklo M, Allison M, Sibley C, et al. Metabolic syndrome and incident peripheral artery disease-the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2015 Nov;243(1):198-203. doi:10.1016/j.atherosclerosis.2015.08.044.
Hirsch AT, Treat-Jacobson D, Krook SH, Hunninghake DB, Criqui MH, Regensteiner JG, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 Sep 19;286(11):1317-24. doi: 10.1001/jama.286.11.1317.
Bhatt DL, Gabriel Steg P, Magnus Ohman E, Hirsch AT, Ikeda Y, Mas J-L, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006 Jan 11;295(2):180-9. doi: 10.1001/jama.295.2.180.
SC M, VS M, ME K, JC W, JA T, MW W, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001 Feb;33(2):251-7; discussion 257-8. doi: 10.1067/mva.2001.112210.
McDermott MM. Exercise training for intermittent claudication. J Vasc Surg. 2017;66(5):1612-1620. doi:10.1016/j.jvs.2017.05.111
Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995;274(12):975-980.
Casella IB, Sartori CH, Faustino CB, Vieira Mariz MP, Presti C, Puech-Leão P, et al. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages. Ann Vasc Surg. 2020;1–9.
Albers M, Romiti M, Brochado-Neto FC, Pereira CAB. Meta-analysis of alternate autologous veinn bypass grafts to infrapopliteal arteries. J Vasc Surg. 2005;42(3):449–55.
van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery. 2004 Aug;28(2):132-137. DOI: 10.1016/s1078-5884(04)00209-6.
SD H, Yapanis M, PJ B, AB W, AW B, DJ A. Peri-operative myocardial injury in patients undergoing surgery for critical limb ischaemia. Eur J Vasc Endovasc Surg 2005 Mar;29(3):301-4. doi: 10.1016/j.ejvs.2004.11.002.
Visser K, MM I, Buth J, GL E, MG H. Duplex scan surveillance during the first year after infrainguinal autologous vein bypass grafting surgery: costs and clinical outcomes compared with other surveillance programs. J Vasc Surg 2001 Jan;33(1):123-30. doi: 10.1067/mva.2001.109745.
CL W, JL M, Westerband A, JD H, DM I. An economic appraisal of lower extremity bypass graft maintenance. J Vasc Surg 2000 Jul;32(1):1-12. doi: 10.1067/mva.2000.107307.
RR L, RC D. Autogenous saphenous vein bypass grafts in femoropopliteal obliterative arterial disease. 1962 Jan;51:62-73.
RP L, SR P, AM K. A reappraisal of the in situ saphenous vein arterial bypass: its use in limb salvage. Surgery 1979 Sep;86(3):453-61.
Ascer E, FJ V, SK G. Bypasses to plantar arteries and other tibial branches: an extended approach to limb salvage. J Vasc Surg 1988 Oct;8(4):434-41.
JA M, AD W, MC D. Clinical and anatomic considerations for surgery in tibial disease and the results of surgery. Circulation 1991 Feb;83(2 Suppl):I81-5.
Ramaswami G, Marin ML. Stent grafts in occlusive arterial disease. Surg Clin North Am. 1999;79(3):597-609. doi:10.1016/s0039-6109(05)70026-8
Markose G, FN M, Bolia A. Subintimal angioplasty for femoro-popliteal occlusive disease. J Vasc Surg 2010 Nov;52(5):1410-6. doi: 10.1016/j.jvs.2010.03.046.
Bolia A, Brennan J, PR B. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989 May;40(3):325. doi: 10.1016/s0009-9260(89)80231-4.
YC C, SW C. Drug-eluting stents and balloons in peripheral arterial disease: evidence so far. Int J Clin Pract 2011 Jun;65(6):664-8. doi: 10.1111/j.1742-1241.2011.02639.x.
JC P, RR S, FO T, SR R, JE P, Garcia F. Expandable intraluminal vascular graft: a feasibility study. Surgery 1986 Feb;99(2):199-205
SHIV KUMAR A, GIRISH N. N, RABI Y, ACHINT A. P, JAMES S. J, TYRONE J. C, et al. Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta-Analysis and Systematic Review of Randomized Clinical Trials. J Interv Cardiol 2015 Jun;28(3):288-95. doi: 10.1111/joic.12202. Epub 2015 May 20.
Popplewell MA, Davies H, Jarrett H, Bate G, Grant M, Patel S, et al. Bypass versus angio plasty in severe ischaemia of the leg-2 (BASIL-2) trial: Study protocol for a randomised controlled trial. Trials. 2016;17(1):1–9.
Hunt BD, Popplewell MA, Davies H, Meecham L, Jarrett H, Bate G, et al. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): Study protocol for a randomised controlled trial. Trials. 2017;18(1):1–10.
Farber A, Rosenfield K, Siami FS, Strong M, Menard M. The BEST-CLI trial is nearing the finish line and promises to be worth the wait. J Vasc Surg. 2019;69(2):470-481.e2.
Castrillon-peña EL, Poveda-conde LC, Suaza-vallejo MC, Vanegas-vidal M, Camilo J, Hernán B. Experiencia de la angioplastía en miembros inferiores en la enfermedad arterial periférica en una clínica privada en el sur de Colombia. 2019;71(3):210–5.
Manzini JL. DECLARACIÓN DE HELSINKI: PRINCIPIOS ÉTICOS PARA LA INVESTIGACIÓN MÉDICA SOBRE SUJETOS HUMANOS Análisis de la 5a Reforma, aprobada por la Asamblea General de la Asociación Médica Mundial en octubre del año 2000, en Edimburgo Acta Bioethica 2000; año VI, nº 2
De Salud M. Hoja 1 de 1 [Internet]. [cited 2019 Mar 7]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Introducción: Existen en la actualidad múltiples intervenciones en cirugía vascular que pueden mejorar el pronóstico. Se pretendió describir frecuencia de amputación, infección y necesidad de reintervención en pacientes con isquemia crítica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f3e2f0368601e35553632c471ed73b
https://repository.urosario.edu.co/handle/10336/25576

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.